Showing 8851-8860 of 20877 results for "".
Beyond the Stiff Neck: Meningitis Detection in Infants and Toddlers
https://reachmd.com/programs/clinicians-roundtable/beyond-the-stiff-neck-meningitis-detection-in-infants-and-toddlers/37110/Despite the success of meningitis vaccination programs, pediatricians must remain vigilant as cases still occur and can be life-threatening if missed. That’s why Dr. Jessica Snowden joins us to share how we can identify subtle behavioral cues, understand age-specific presentations, and diagnose patiEpithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
https://reachmd.com/programs/living-rheum/epithelial-cell-activation-in-sjogrens-a-new-target-in-chronic-inflammation/36341/New research into primary Sjögren’s disease reveals how epithelial cells may actively drive chronic inflammation through gene-level changes. In this AudioAbstract, Ryan Quigley walks through the findings from an in vitro study examining the effects of prolonged interferon gamma exposure on salivaryAcne, Eczema, and Psoriasis: Improving Treatment Adherence in Younger Patients
https://reachmd.com/programs/dermconsult/acne-eczema-and-psoriasis-improving-treatment-adherence-in-younger-patients/35502/When treating adolescents and young adults with acne, eczema, and psoriasis, getting them to adhere to their regimen may be difficult. However, practical strategies like explaining the therapy and its side effects and encouraging patients to set reminders can help them stay on track and optimize theUpdates from MINT: Inebilizumab Reduces Relapses and Rescue Therapy Use
https://reachmd.com/programs/neurofrontiers/updates-from-mint-inebilizumab-reduces-relapses-and-rescue-therapy-use/35869/After the primary findings from the Myasthenia Gravis Inebilizumab Trial (MINT) demonstrated the clinical benefit and safety of inebilizumab for patients with generalized myasthenia gravis (gMG), a secondary analysis evaluated inebilizumab’s impact on exacerbation rates and the need for rescue theraHow Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
https://reachmd.com/programs/neurofrontiers/how-diagnostic-delays-in-gmg-impact-disease-severity-outcomes-and-quality-of-life/35492/The symptom variability, prolonged asymptomatic periods, and inconsistent presentations of generalized myasthenia gravis (gMG) often lead to significant diagnostic delays and misdiagnoses. Based on recent studies, these delays then correlate with increased disease severity, longer time to symptom coQuality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
https://reachmd.com/programs/neurofrontiers/quality-of-life-challenges-in-gmg-care-navigating-the-invisible-burden/35493/Generalized myasthenia gravis (gMG) presents with highly variable symptoms that can significantly impact a patient’s quality of life, often in ways that are invisible to others. That’s why Dr. Maxwell Levy joins us to discuss these unmet needs and how we can address them with various clinical strateFPIES in Infants: Optimizing Care and Addressing Complications
https://reachmd.com/programs/frontlines-food-allergies/fpies-in-infants-optimizing-care-and-addressing-complications/30042/Managing food protein-induced enterocolitis syndrome (FPIES) in infants can come with challenges—however, using strategies like identifying trigger foods and maintaining proper nutrition can be pivotal in ensuring effective outcomes. Join Dr. Anna Nowak-Wegryzn, Professor of Pediatrics at the New YoThe Lingering Impact of Covid-19
https://reachmd.com/programs/what-your-patients-are-talking-about/tbd/15487/What is immunity gap? Tune in.Assessing Interest in Oral vs. LAI ART Among Women with HIV
https://reachmd.com/programs/clinicians-roundtable/assessing-interest-in-oral-vs-lai-art-among-women-with-hiv/24151/There’s an overall preference for LAI ART among women with HIV, but various factors impact a patient’s preference. Learn more.Breastfeeding with MS: Monoclonal Antibodies May Not Impact Child Development
https://reachmd.com/programs/neurofrontiers/breastfeeding-with-ms-monoclonal-antibodies-may-not-impact-child-development/24093/When taken while breastfeeding, monoclonal antibodies may not impact the health or development of infants. Dive into the findings.